- Pharmaceutical Technology
Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here
X

Endo International agrees to acquire BioSpecifics Technologies for $540m

BioSpecifics will receive a royalty stream from Endo for the latter’s collagenase-based therapies. Credit: naturwohl-gesundheit on Pixabay.